Pharmaceutical Stability Testing Market is Anticipated to Witness High Growth Owing to Growing R&D Investments

Pharmaceutical Stability and Storage Services Market 

The pharmaceutical stability and storage services market provides products and services for monitoring degradation of drugs during storage and distribution. Stability testing helps ensure safety, efficacy and quality of drugs by monitoring their chemical, physical or microbiological changes overtime under the influence of various environmental factors such as temperature, humidity and light. It plays a vital role in drug development process and shelf life determination of pharmaceutical products. The growing R&D investment in pharmaceutical industry along with stringent regulations for drug development and approval process is driving the demand for stability testing services.

The Global pharmaceutical stability and storage services market is estimated to be valued at US$ 3.18 Bn in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Pharmaceutical Stability And Storage Services Market Growth are Intertek Group plc, Eurofins Scientific, SGS Société Générale de Surveillance SA., Q Laboratories, BioLife Solutions Inc., Cencora, Inc., Alloga, PCI Pharma Services, Pharmaserv GmbH, Catalent, Inc, Almac Group, Charles River Laboratories, Lucideon, Alcami Corporation, Element Materials Technology, Nelson Laboratories, LLC, ALS. These players are focusing on expansion of their stability testing facilities across major markets to tap the growth opportunities.

The growing generic drug market and increasing biosimilars approvals present huge opportunities for pharmaceutical stability testing market. Further, expansion of manufacturing facilities by major pharmaceutical companies in developing regions of Asia Pacific and Latin America will boost the demand for local stability testing services.

Key players are expanding their global footprint through mergers and acquisitions. For instance, in 2021, Eurofins Scientific acquired Central Glass Co., Ltd. stability testing business in Japan to expand its presence in Asia Pacific region. Similarly, partnerships with CROs, universities and pharmaceutical companies will help key players penetrate untapped markets.

Market Drivers
Stringent regulatory norms: Stringent stability testing guidelines by regulatory agencies such as FDA, EMA and WHO ensure safety of drugs. Developing robust stability testing protocols as per these guidelines is driving the market.

R&D investment: Growing R&D investment in pharmaceutical industry results in new product development which requires extensive stability testing services. This is a key growth driver.

Market Restraints
High cost of stability testing: Cost of long term stability testing required as per regulatory guidelines is high which increases cost of drug development. This can limit market growth.

Lack of harmonization: Variations in stability testing guidelines across regions increases complexity for global clinical trials which negatively impacts the market.

Segment Analysis

The pharmaceutical stability and storage services market is dominated by the stability testing sub segment. Stability testing is crucial to determine the shelf-life and expiry dates of pharmaceutical products. It helps ensure drug safety and efficacy over time under optimal storage and transportation conditions. Regulatory authorities require stability testing data before approving drug launches. Pharmaceutical companies outsource stability testing as it requires specialized equipment and expertise to conduct accurate long-term testing as per Good Laboratory Practice (GLP) standards.


Global Analysis

Regionally, North America dominates the pharmaceutical stability and storage services market currently. This can be attributed to the large presence of pharmaceutical companies and stringent regulations requiring stability data in the region. The United States is the largest market. However, the Asia Pacific region is poised to grow the fastest during the forecast period. This is due to rising pharmaceutical manufacturing in countries like India and China coupled with increasing investments by market players to expand capabilities in these emerging economies. Furthermore, regulatory harmonization with international regulatory standards is also boosting outsourcing of stability testing to Asian service providers.

Get more insights on Pharmaceutical Stability and Storage Services Market